Phase 3b STARDUST study data on crohn’s disease
Vice President and Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC, talks about data fro...
275 articles
Vice President and Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC, talks about data fro...
Todd Norwood, Director of Clinical Services discusses Physera, a telehealth company that offers consumers/patients virtual physical therapy with license...
Edouard Saget, Co-Founder, Board Member, and Co-CEO of OrthoGrid Systems, a Salt Lake City-based global medtech leader offering intraoperative alignmen...
Tzvia Bader, co-founder, and CEO talks about TrialJectory, a first-of-its-kind AI-powered platform that uses self-reported clinical data to match cancer...
Matthew Bauer, L.Ac., President at The Acupuncture Now Foundation, a non-profit organization discusses the practice of acupuncture, the foundation, and ...
Nimesh Patel talks about Redbird Bioscience, Oklahoma's largest commercial medical cannabis processor. He discusses best practices and guidance on wha...
Sinai, New York discusses Janssen's announcement of their new two-year data from the long-term extension of the Phase 3 UNIFI study of STELARA® (usteki...
Elizabeth Cherot talks about advances in opioid alternatives, shares what she’s doing to help her patients and encourages women to speak with their do...
Doug Manion’s current work developing cancer therapeutics has been uniquely informed by his connections to family and friends who have suffered from t...
Jonathan Cheng with Merck Research Laboratories discusses data presented at the European Society for Medical Oncology (ESMO) 2019 Congress on the phas...